The U.S. is ready to roll out the COVID vaccine once it’s approved for kids age 5-11

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot center on Oct. 1, in San Rafael, Calif

. Justin Sullivan/Getty Images

toggle caption

hide caption

Justin Sullivan/Getty Images

Under the plan, the administration will work with state and regional leaders to make the vaccine available at more than 25,000 pediatricians workplaces and primary care sites and 100 childrens healthcare facility systems as well as drug stores, schools and neighborhood health. “Thats why were making sure that its relied on messengers with clinical credibility who go out there and talk about these vaccines,” Murthy stated.

The White House said on Wednesday that it is prepared to quickly present COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is authorized by the Food and Drug Administration and advised by the Centers for Disease Control and Prevention. The administration has actually purchased enough doses for all 28 million children in that age group and will provide it in smaller sized bundles with essential products like smaller sized needles to make it simpler to get to physicians, pediatricians and community university hospital, Biden administration authorities said. “Should the FDA and CDC license the vaccine, we will be all set to get shots in arms,” said White House coronavirus reaction coordinator Jeff Zients during a news briefing Wednesday early morning.

. Justin Sullivan/Getty Images

The White House stated on Wednesday that it is prepared to quickly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is licensed by the Food and Drug Administration and suggested by the Centers for Disease Control and Prevention. The vaccine could be cleared for usage in children ages 5 to 11 within a couple of weeks, authorities stated. White House authorities said they were announcing the strategy to inoculate children ages 5 to 11 prior to the vaccine was authorized for that age group so they might be “operationally prepared” to deploy the doses as quickly as the approval came.

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on Oct. 1, in San Rafael, Calif

The vaccine could be cleared for use in children ages 5 to 11 within a number of weeks, authorities said. The FDAs independent advisory committee conference is scheduled for Oct. 26, and the CDCs independent advisory committee conference is set for Nov. 2 and 3. The Pfizer vaccine presently has complete approval for use in grownups, and the federal government has authorized it for emergency usage in children ages 12 to 17. White House authorities stated they were revealing the strategy to inoculate children ages 5 to 11 prior to the vaccine was approved for that age so they might be “operationally prepared” to deploy the dosages as quickly as the approval came.

Leave a Reply

Your email address will not be published. Required fields are marked *